ID   JC-39
AC   CVCL_A1EN
SY   JFCR-Colorectal-39
DR   cancercelllines; CVCL_A1EN
DR   Cosmic; 2811063
DR   Wikidata; Q102114299
RX   PubMed=28179481;
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; HGNC:583; APC; Simple; p.Arg216Ter (c.646C>T); ClinVar=VCV000127312; Zygosity=Unspecified (PubMed=28179481).
DI   NCIt; C2955; Colorectal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 19-12-24; Version: 6
//
RX   PubMed=28179481; DOI=10.1158/1535-7163.MCT-16-0578;
RA   Tanaka N., Mashima T., Mizutani A., Sato A., Aoyama A., Gong B.,
RA   Yoshida H., Muramatsu Y., Nakata K., Matsuura M., Katayama R.,
RA   Nagayama S., Fujita N., Sugimoto Y., Seimiya H.;
RT   "APC mutations as a potential biomarker for sensitivity to tankyrase
RT   inhibitors in colorectal cancer.";
RL   Mol. Cancer Ther. 16:752-762(2017).
//